USPTO serial 79187184
PCAS
Reviewed by CopyMark Law Group
Reg. 5211290Status 404
- Filing date
- Status date
- Registration date
- May 30, 2017
- Examiner
- SMITH, REBECCA A
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PCAS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Maurice B. Pilosof
MAURICE B. PILOSOF MAURICE B. PILOSOF, ESQPO BOX 691937.WEST HOLLYWOOD, CA 90069Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical products for use in industry, science, photography, as well as in agriculture, horticulture and forestry; chemical preparations for soldering, adhesive substances for industrial use; unprocessed artificial resins, unprocessed plastics; chemical reagents other than for medical or veterinary use | SECTION 71 - CANCELLED | — |
| 004 | Industrial oils and greases, lubricants | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical, veterinary and sanitary products for medical purposes, namely, synthesis intermediates and active ingredients used in the manufacture of medicinal, active pharmaceutical ingredients (APIs), additives and chemical intermediates, antimicrobial preparations for preventing bacteria; pharmaceutical and medicinal preparations and substances, namely, bacteriostats, antibiotics, medicinal preparations for the treatment of infectious diseases, medicinal herbal extracts for medical purposes; Pharmaceutical products, namely, Active Pharmaceutical ingredients (API's) for human and veterinary use; medical, biological, biotechnological, protein, virological, immunological, bacteriological, chemical, enzymatic and products for medical and veterinary use, namely, mixed biological preparations for the prevention and treatment of infectious diseases, complex molecules for life science and innovative technologies, bacteriological preparations, chemical reagents; diagnostic preparations for medical, pharmaceutical and veterinary use; cell, microorganism or virus cultures for medical and veterinary use; adjuvants for medical or veterinary use; antibiotics, pharmaceutical preparations for medical and veterinary use, namely, nucleic acids, proteins, recombinant proteins, peptides, peptide antigens, blood serum, for medical, pharmaceutical and veterinary use; biological products and preparations for medical use, namely, medicine, diagnostic reagents made from human, animal and microorganism, for the prevention, diagnosis or treatment of diseases and cellular veterinary products and preparations, for use in biotechnology, particularly for production of recombinant proteins, monoclonal antibodies, for biomedical diagnostic, prophylactic, therapeutic and clinical application, namely, excipients; proteins arrays for medical or veterinary use; micro-organisms for medical use, namely, bacteria, algae, including cell lines, cell cultures and cell expression systems from mammals used for biomolecule production | SECTION 71 - CANCELLED | — |
| 042 | Scientific research; industrial research in the field of chemistry, biochemistry, enzymology, biology, microbiology, cell biology, pharmaceuticals, biotechnology; research and development of new products for others; biological research; technical research in the field of chemistry, biochemistry, enzymology, biology, microbiology, cell biology, pharmaceuticals, biotechnology and technical research for others relating to medical devices and pharmaceuticals in the field of veterinary | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PCAS
- Other trademarks owned by PCAS
- Other trademarks owned by PRODUITS CHIMIQUES AUXILIAIRES ET DE SYNTHESE
- Other trademarks in Class 001
- Other trademarks in Class 004
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named PCAS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 20, 2026 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Aug 20, 2026 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Sep 14, 2024 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Aug 28, 2024 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Aug 28, 2024 | INPC | INVALIDATION PROCESSED | — |
| Aug 16, 2024 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Dec 15, 2023 | C71T | CANCELLED SECTION 71 | — |
| May 30, 2022 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 28, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 7, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 7, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 30, 2017 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 11, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 30, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 8, 2017 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 23, 2017 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Mar 14, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 14, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 22, 2017 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 22, 2017 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 22, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 4, 2017 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 24, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 24, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 24, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 24, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 24, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 23, 2017 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jan 17, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 17, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 17, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 17, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 17, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 14, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 14, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 13, 2017 | ALIE | ASSIGNED TO LIE | — |
| Dec 14, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 2, 2016 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 15, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 15, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 15, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 14, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 14, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 8, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 8, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 2, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |